Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication.

Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK, Chen SH.

J Infect Dis. 2008 Mar 15;197(6):854-7. doi: 10.1086/527326.

2.

Developments towards antiviral therapies against enterovirus 71.

Wu KX, Ng MM, Chu JJ.

Drug Discov Today. 2010 Dec;15(23-24):1041-51. doi: 10.1016/j.drudis.2010.10.008. Review.

PMID:
20974282
3.

Strategies to develop antivirals against enterovirus 71.

Kuo RL, Shih SR.

Virol J. 2013 Jan 22;10:28. doi: 10.1186/1743-422X-10-28. Review.

4.

Update on enterovirus 71 infection.

Huang PN, Shih SR.

Curr Opin Virol. 2014 Apr;5:98-104. doi: 10.1016/j.coviro.2014.03.007. Review.

PMID:
24727707
5.

Development of antiviral agents toward enterovirus 71 infection.

Pourianfar HR, Grollo L.

J Microbiol Immunol Infect. 2015 Feb;48(1):1-8. doi: 10.1016/j.jmii.2013.11.011. Review.

6.

Animal models of enterovirus 71 infection: applications and limitations.

Wang YF, Yu CK.

J Biomed Sci. 2014 Apr 17;21:31. doi: 10.1186/1423-0127-21-31. Review.

7.

Drug discovery in enteroviral infections.

Chen TC, Shih SR.

Infect Disord Drug Targets. 2011 Jun;11(3):337-45. Review.

PMID:
21488833
8.

Combating enterovirus replication: state-of-the-art on antiviral research.

Thibaut HJ, De Palma AM, Neyts J.

Biochem Pharmacol. 2012 Jan 15;83(2):185-92. doi: 10.1016/j.bcp.2011.08.016. Review.

PMID:
21889497
9.

The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.

Li C, Wang H, Shih SR, Chen TC, Li ML.

Curr Med Chem. 2007;14(8):847-56. Review.

PMID:
17430140
10.

[Molecular Mechanism of Action of hnRNP K and RTN3 in the Replication of Enterovirus 71].

Li L, Zhong H, Fan M, Kui L, Li H, Zhang J.

Bing Du Xue Bao. 2015 Mar;31(2):197-200. Review. Chinese.

PMID:
26164948
11.

Recent developments in antiviral agents against enterovirus 71 infection.

Tan CW, Lai JK, Sam IC, Chan YF.

J Biomed Sci. 2014 Feb 12;21:14. doi: 10.1186/1423-0127-21-14. Review.

12.

Enterovirus infections: diagnosis and treatment.

Sawyer MH.

Semin Pediatr Infect Dis. 2002 Jan;13(1):40-7. Review.

PMID:
12118843
13.

Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.

Galabov AS, Nikolova I, Vassileva-Pencheva R, Stoyanova A.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(2):91-9. doi: 10.1515/prilozi-2015-0057. Review.

PMID:
27442375
14.

[Infection mechanism of enterovirus 71].

Nishimura Y.

Uirusu. 2012 Jun;62(1):121-8. Review. Japanese.

15.

Genetic evolution of enterovirus 71: epidemiological and pathological implications.

Bible JM, Pantelidis P, Chan PK, Tong CY.

Rev Med Virol. 2007 Nov-Dec;17(6):371-9. Review.

PMID:
17487831
16.

[Use of new antiviral preparations, nuclease enzymes, in neuroviral infections].

Lobzin VS, Sichko ZhV.

Voen Med Zh. 1973 Aug;(8):47-50. Review. Russian. No abstract available.

PMID:
4375882
17.

Current status of anti-picornavirus therapies.

Barnard DL.

Curr Pharm Des. 2006;12(11):1379-90. Review.

PMID:
16611122
18.

Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.

Stein DA.

Curr Pharm Des. 2008;14(25):2619-34. Review.

PMID:
18991679
19.

Molecular strategies to inhibit the replication of RNA viruses.

Leyssen P, De Clercq E, Neyts J.

Antiviral Res. 2008 Apr;78(1):9-25. doi: 10.1016/j.antiviral.2008.01.004. Review.

PMID:
18313769
20.

Development of antiviral agents for enteroviruses.

Chen TC, Weng KF, Chang SC, Lin JY, Huang PN, Shih SR.

J Antimicrob Chemother. 2008 Dec;62(6):1169-73. doi: 10.1093/jac/dkn424. Review.

Items per page

Supplemental Content

Support Center